InvestorsHub Logo
Followers 19
Posts 6071
Boards Moderated 3
Alias Born 05/23/2019

Re: Wolf-man jack post# 52690

Sunday, 07/21/2019 2:13:03 AM

Sunday, July 21, 2019 2:13:03 AM

Post# of 83094
Wolf prediction. Soon the FDA is going to Weed out the bad actors, starting with all these internet companies such as New Harvest Pharms in my opinion. Gras could be the catalyst to help make this happen. How many of those fly by nightersvare going to be able to continue or enter the market. Why would someone play down the gras requirement on this forum if it wasn’t a valuable procurement. August to late October seems to me to be the window of time for the FDA to come up with a solution to regulate the market. Possibly the market CVSI is in. I think the Food & Beverage with infusions will take longer. Got this article from the Y. ‘‘This is my opinion so take it with a grain of salt and a hit of your favorite wacky weed you understand, Wolf

A coalition of 37 state attorneys general urge FDA to cooperate with states on CBD regulation

In public comment submitted to FDA on July 16, 2019, a coalition of 37 state attorneys general urged FDA to cooperate with the states in protecting consumers from false advertising on cannabis-derived products such as CBD, and the potential hazards of consuming such products in certain populations.

“We write to express our hope that the FDA continues to explore manufacturing, testing, and marketing best practices so that consumers are not at risk of misleading advertising or harm to their health from dangerous additives or undisclosed risks of use,” writes the coalition. “A crucial element of FDA regulation and oversight should be an on-going assessment of the potential risks or benefits of these products, particularly for specific populations such as pregnant women, adolescents and children, and the elderly. How these products interact with other dietary or pharmaceutical products should be included in this assessment. It is also important that companies not mislead consumers. Scientific and medical data from the FDA would assist in meaningful enforcement of advertising laws and regulations by the states.”

http://www.nutritionaloutlook.com/regulatory/coalition-37-state-attorneys-general-urge-fda-cooperate-states-cbd-regulation